Investigating how certain compounds from gut bacteria may help delay cognitive decline.
Role of Neuroprotective Indoles in Delaying the Onset of Cognitive Decline
This study is looking at how certain natural substances made by gut bacteria might help protect the brain and slow down early signs of memory loss related to Alzheimer's disease, and it could involve patients trying these compounds to see how they affect their thinking over time.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-10491044 on NIH RePORTER |
What this research studies
This research explores the role of neuroprotective molecules, specifically indoles produced by gut bacteria, in potentially delaying the onset of mild cognitive decline associated with Alzheimer's disease. The study examines how these compounds can promote cellular protection and reduce inflammation, which are critical factors in cognitive health. By analyzing the effects of these molecules on the brain, the research aims to identify new therapeutic strategies for managing cognitive decline. Patients may be involved in trials assessing the impact of these compounds on cognitive function over time.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults experiencing mild cognitive decline or those at risk for Alzheimer's disease.
Not a fit: Patients with advanced Alzheimer's disease or other severe cognitive impairments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that help preserve cognitive function in aging individuals.
How similar studies have performed: Previous studies have shown promising results with similar approaches, indicating that gut-derived compounds can positively influence cognitive health.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Fang, Xiang — University of Texas Med Br Galveston
- Study coordinator: Fang, Xiang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.